home About Us People Portfolio News Contact Us Fund I Investor Login » Fund II Investor Login » Fund III Investor Login »

news

Tag: 2014

Dec15Nevro Announces First Draw Down of $20 Million Under Term Loan Facility with CRG »


Menlo Park, Calif., December 15, 2014 – Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, is...

Read More »

Dec10Good Start Genetics, IviGen and Igenomix Announce Exclusive Relationship in Reproductive Testing »


Partner on Expansive Suite of Advanced, Genetics-based Products to Manage Infertility    CAMBRIDGE, Mass. and VALENCIA, Spain, December 10, 2014 -- Good Start Genetics®, Inc., a commercial-stage molecular genetic information...

Read More »

Dec8NanoString Technologies Updates Prosigna FDA Labeling to Provide Greater Insight into Probability of Breast Cancer Recurrence Between Year 5 and 10 After Diagnosis »


The Prosigna Score Provides Important Information for Node-Negative and Node-Positive (1-3 Nodes) Breast Cancer Patients in the First 5 Years and 5 to 10 Years After Diagnosis    Seattle --(BUSINESS WIRE...

Read More »

Dec4Corium Announces Closing Of Expanded Term Loan Facility With CRG »


MENLO PARK, Calif., December 4, 2014 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that it...

Read More »

Nov10TriVascular Technologies, Inc. and CRG LP Amend and Restate Term Loan Facility »


Santa Rosa, CA, November 10, 2014 – TriVascular Technologies, Inc. (Nasdaq: TRIV) and CRG LP (formerly known as Capital Royalty) and its affiliate funds (“CRG”) today announced that they...

Read More »

Nov10NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate »


Category I CPT Codes Will Expand Patient Access to Novel Treatment for Common Condition that Significantly Impacts Quality of Life   Pleasanton, Calif. – November 10, 2014 – NeoTract, Inc., a medical...

Read More »

Oct30Blue Belt Technologies Closes $40 Million in Debt Financing from CRG »


MINNEAPOLIS – October 30, 2014 - Blue Belt Technologies, Inc. and CR Group (“CRG”) announced that they have closed a senior secured term loan for up to $40 million of...

Read More »

Oct27Biodesix Announces Inclusion of VeriStrat in Updated NCCN Guidelines »


Guidelines provide evidence-based, consensus-driven recommendations for managing cancer   Biodesix Inc., a molecular diagnostics company dedicated to advancing precision medicine and improved patient care, today announced that its ...

Read More »

Oct15TriVascular Announces FDA Approval of CustomSeal(TM) Technology for the Ovation Prime(R) System »


Customized Sealing Technology Enables Faster Procedure Times, Preserves the Aortic Neck and Provides an Optimized Seal Tailored to Each Patient's Specific Anatomy    Santa Rosa, Calif., Oct. 15, 2014 (GLOBE...

Read More »

Oct9Astute Medical and CRG Announce FDA Milestone Under Term Loan Agreement »


San Diego – October 9, 2014 – Astute Medical, Inc. and CRG today announced that Astute recently achieved a milestone under the terms of its existing term loan agreement with CRG. Under...

Read More »

Sep9Biodesix Receives Highmark Blue Cross Blue Shield Coverage for VeriStrat Test »


-- Lung cancer diagnostic deemed medically necessary to guide treatment decisions –   Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today announced that its VeriStrat...

Read More »

Jun9Exagen Diagnostics Launches Prognostic Panel »


Albuquerque, N.M., June 9, 2014 – Exagen Diagnostics Inc., a leading medical diagnostic company focused in rheumatology, today announced the addition of the Avise SLE Prognostic panel to its testing services. ...

Read More »

May19AFT Pharmaceuticals Closes Important Financing To Spur Global Growth »


May 19, 2014 – Innovative Australasian pharmaceutical sales and development company, AFT Pharmaceuticals Ltd (AFT), has finalised an equity and structured debt funding package with Capital Royalty Partners (Houston, Boulder, New York)...

Read More »

May6NanoString Technologies Receives Canadian Market Approval for its Prosigna Breast Cancer Prognostic Gene Signature Assay »


The Prosigna Assay on the nCounter Dx Analysis System Provides Compelling Clinical Data, Clear Patient Report, and Localized Processing in Qualified Canadian Labs    Seattle --(BUSINESS WIRE)--...

Read More »

Apr29TriVascular Announces FDA-Approved Expansion of Ovation® and Ovation Prime™ Indication Statements »


More Patients Now Have Access to a Less Invasive, On-Label, Clinically Proven Endovascular Aortic Repair (EVAR) Solution   Santa Rosa, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV),...

Read More »

Apr22TriVascular Technologies, Inc. Announces the Closing of Its Initial Public Offering »


Santa Rosa, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime™ Abdominal Stent Graft System, today announced the closing of its initial public...

Read More »

Apr10AVEO and Biodesix Partner to Co-Develop and Commercialize Ficlatuzumab with a Companion Diagnostic for Treatment of NSCLC »


Biodesix to Fund Proof of Concept Study    AVEO Oncology (NASDAQ: AVEO) and Biodesix, Inc. today announced that they have entered into a worldwide agreement to develop and commercialize...

Read More »

Apr9Tandem Diabetes Care and Capital Royalty Amend and Restate Term Loan Facility »


San Diego, CA – April 9, 2014 – Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) and Capital Royalty Partners II, L.P. and its affiliate funds (“Capital Royalty”) today announced...

Read More »

Apr3NanoString Technologies Announces $45 Million Term Loan Agreement with Capital Royalty »


Seattle, Washington – April 3, 2014 – NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into...

Read More »

Mar17Good Start Genetics Announces Collaboration with PerkinElmer to Bring GoodStart Select ™ Carrier Screening Tests to Broader Women’s Health Market »


Agreement Will Greatly Expand Access to Reproductive Health Community    CAMBRIDGE, Mass., March 17, 2014 - Good Start Genetics®, Inc., an innovative molecular genetic information company, today announced a strategic...

Read More »

Mar3RainDance Technologies Closes Series E Financing with GE »


GE Ventures support RainDance’s vision to make liquid biopsy a commercial reality   Billerica, Mass. – March 3, 2014 – RainDance Technologies, Inc., an innovative genomics tools company making molecular...

Read More »

Mar3Biodesix Receives CE Mark for VeriStrat Specimen Collection and Shipping Kit »


-- Blood-based protein diagnostic predicts differential treatment outcomes for non-small cell lung cancer --   Mar 3, 2014 - Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today...

Read More »

Feb12Biodesix and Capital Royalty Close Financing Transaction »


BOULDER, Colorado – February 12, 2014 – Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that the company closed a structured debt financing with Capital Royalty...

Read More »

Jan13Good Start Genetics Announces Contract with Tufts Health Plan to Cover GoodStart Select ™ Carrier Screening Test »


CAMBRIDGE, Mass., January 13, 2014 -- Good Start Genetics®, Inc., an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability, today announced that the company has signed...

Read More »